Lund Melanoma Study Group
111 – 120 of 258
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Protein Expression in Metastatic Melanoma and the Link to Disease Presentation in a Range of Tumor Phenotypes
- Contribution to journal › Scientific review
-
Mark
Increased cancer risk in families with pediatric cancer is associated with gender, age, diagnosis, and degree of relation to the child
(2020) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29(11). p.2171-2179
- Contribution to journal › Article
-
Mark
Desloratadine and loratadine use associated with improved melanoma survival
- Contribution to journal › Letter
-
Mark
The Role of PTEN Loss in Immune Escape, Melanoma Prognosis and Therapy Response
- Contribution to journal › Article
-
Mark
Long-term outcome of pT1a–b, cN0 breast cancer without axillary dissection or staging : a prospective observational study of 1543 women
- Contribution to journal › Article
-
Mark
Desloratadine and loratadine stand out among common H1-antihistamines for association with improved breast cancer survival
- Contribution to journal › Article
-
Mark
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
- Contribution to journal › Article
-
Mark
Novel functional proteins coded by the human genome discovered in metastases of melanoma patients
- Contribution to journal › Article
-
Mark
Analysis of DNA methylation patterns in the tumor immune microenvironment of metastatic melanoma
- Contribution to journal › Article
-
Mark
Effect of delay between nuclear medicine scanning and sentinel node biopsy on outcome in patients with cutaneous melanoma
- Contribution to journal › Article
